CD36 and Disorder of lipid metabolism: The mixed probiotics intervention alleviated oxidative stress and lipid metabolic disorder in VPA-treated mice by inhibiting the pro-oxidant CYP2E1 level, activating the Nrf2/antioxidant enzyme pathway, and decreasing the CD36 and DGAT2 levels, accompanied with the restoration of gut microbiota dysbiosis.